← All trials
NCT04467983
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2020
- Primary completion
- Feb 28, 2022
- Completion date
- Aug 31, 2022
- First posted
- Jul 13, 2020
- Last posted
- Jul 14, 2020
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Osteoporosis Center of Delaware CountyLead sponsor
- Radius HealthCollaborator
- Crozer Chester Medical Center, PennsylvaniaSponsor investigator
- Crozer Chester Medical Center, PennsylvaniaStudy director
- Crozer Chester Medical Center, PennsylvaniaCollaborator
- Osteoporosis Center of Delaware CountySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.